Health Care • Biotechnology: Pharmaceutical Preparations
$28.24 ▼ -1.75
(-5.83%)
MKT CAP: $1.06B • VOL: 335.3K
52W L $27 52W H $55
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$24
MEDIAN
$32
MEAN
$32
HIGH
$38
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HROW TAPE
HROW // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $34.17 | $32.48 | 2025-02-14 | $25.70 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $35.58 | $33.32 | 2025-02-06 | $26.55 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $32.19 | $31.06 | 2025-01-29 | $27.11 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $28.80 | — | 2025-01-17 | $27.68 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $24.85 | $26.83 | 2025-01-09 | $25.13 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $33.61 | $29.37 | 2024-12-18 | $24.57 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $27.39 | $28.52 | 2024-12-04 | $26.26 | -4.3% | 48% | C |